Malignancy-related 67kDa laminin receptor in adenoid cystic carcinoma. Effect on migration and beta-catenin expression.
Vanessa Morais Freitas, Letícia Nogueira da Gama de Souza, Elaine Cyreno Oliveira, Cristiane Furuse, Vera Cavalcanti de Araújo, Ruy Gastaldoni Jaeger
Index: Oral Oncol. 43(10) , 987-98, (2007)
Full Text: HTML
Abstract
Adenoid cystic carcinoma is a malignant salivary gland neoplasm with recurrence and metastasis. We studied the expression of a malignancy-related non-integrin laminin receptor, the 67LR, in this neoplasm. Immunohistochemistry showed 67LR in adenoid cystic carcinoma. This receptor binds a sequence of laminin beta1 chain, the YIGSR peptide. We studied the effect of 67LR and YIGSR in cells (CAC2) from adenoid cystic carcinoma. Three-dimensional cultures of cells embedded into either laminin-111 gel (controls) or YIGSR-enriched laminin-111 (treated) were prepared and studied by light microscopy. CAC2 cells treated with YIGSR appeared fibroblast-like, while control cells were epithelioid. Blockage of 67LR by antibody abolished YIGSR effect in three-dimensional cultures. We analysed the relevance of 67LR and YIGSR on beta-catenin expression in CAC2 cells. Immunofluorescence and immunoblot showed that YIGSR decreased beta-catenin, while blockage of 67LR restored the presence of this molecule. The 67LR and YIGSR induced fibroblast-like morphology in CAC2 cells, with disruption of cell-cell contacts and decrease of beta-catenin. These features resemble epithelial-mesenchymal transition (EMT). EMT also increases cell migration. In monolayer assays YIGSR increased migration of CAC2 cells. We conclude that 67LR and YIGSR are involved in epithelial-mesenchymal transition, modulation of beta-catenin expression, and migratory activity of CAC2 cells.
Related Compounds
Related Articles:
2011-03-01
[Integr. Biol. (Camb.) 3(3) , 185-96, (2011)]
2006-05-01
[FASEB J. 20(7) , 906-15, (2006)]
2005-05-01
[J. Biomed. Mater. Res. B. Appl. Biomater. 73(2) , 375-82, (2005)]
Laminin-111-derived peptides and cancer.
2013-01-01
[Cell Adh. Migr. 7(1) , 150-256, (2013)]
2009-12-24
[J. Med. Chem. 52(24) , 7966-9, (2009)]